ICOSLG Products By Gene Name

MAB100), Recombinant Human B7-H2 Fc Chimera (Catalog # 165-B7) stimulates proliferation in PHA-activated human T cells in a dose-dependent manner (orange line). Under these conditions, proliferation elicited by Rec-ombinant Human B7-H2 Fc Chimera (3 µg/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human B7-H2 Monoclonal Antibody (Catalog # MAB1651). The ND₅₀ is typically 1-4 µg/mL." class="big_lightbox"> MAB100), Recombinant Human B7-H2 Fc Chimera (Catalog # 165-B7) stimulates proliferation in PHA-activated human T cells in a dose-dependent manner (orange line). Under these conditions, proliferation elicited by Rec-ombinant Human B7-H2 Fc Chimera (3 µg/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human B7-H2 Monoclonal Antibody (Catalog # MAB1651). The ND₅₀ is typically 1-4 µg/mL." alt="In the presence of Human CD3e Monoclonal Antibody (20 ng/mL, Catalog # MAB100), Recombinant Human B7-H2 Fc Chimera (Catalog # 165-B7) stimulates proliferation in PHA-activated human T cells in a dose-dependent manner (orange line). Under these conditions, proliferation elicited by Rec-ombinant Human B7-H2 Fc Chimera (3 µg/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human B7-H2 Monoclonal Antibody (Catalog # MAB1651). The ND₅₀ is typically 1-4 µg/mL." class="big_thumb" />

9736-CS) is coated at 0.5 µg/mL, Recombinant Cynomolgus B7-H2 Chimera (Catalog # 9900-B7) binds with an ED₅₀ of 4-20 ng/mL." class="big_lightbox"> 9736-CS) is coated at 0.5 µg/mL, Recombinant Cynomolgus B7-H2 Chimera (Catalog # 9900-B7) binds with an ED₅₀ of 4-20 ng/mL." alt="When Recombinant Cynomolgus ICOS Fc Chimera (Catalog # 9736-CS) is coated at 0.5 µg/mL, Recombinant Cynomolgus B7-H2 Chimera (Catalog # 9900-B7) binds with an ED₅₀ of 4-20 ng/mL." class="big_thumb" />

168-CS) that produces 50% the optimal binding response is found to be approximately 10-100 ng/mL." class="big_lightbox"> 168-CS) that produces 50% the optimal binding response is found to be approximately 10-100 ng/mL." alt="When Recombinant Rat B7-H2 Fc Chimera (Catalog # 10419-B7) is immobilized at 1.0 µg/mL (100 µL/well), the concentration of Recombinant Mouse ICOS Fc Chimera (Catalog # 168-CS) that produces 50% the optimal binding response is found to be approximately 10-100 ng/mL." class="big_thumb" />

169-CS) is immobilized at 10 µg/mL, 100 µL/well, the concentration of Biotinylated Recombinant B7-H2 Isoform 3 Fc Chimera Avi-tag (Catalog # AVI10028) that produces 50% of the optimal binding response is approximately 10-50 µg/mL." class="big_lightbox"> 169-CS) is immobilized at 10 µg/mL, 100 µL/well, the concentration of Biotinylated Recombinant B7-H2 Isoform 3 Fc Chimera Avi-tag (Catalog # AVI10028) that produces 50% of the optimal binding response is approximately 10-50 µg/mL." alt="When Recombinant Human ICOS Fc Chimera (Catalog # 169-CS) is immobilized at 10 µg/mL, 100 µL/well, the concentration of Biotinylated Recombinant B7-H2 Isoform 3 Fc Chimera Avi-tag (Catalog # AVI10028) that produces 50% of the optimal binding response is approximately 10-50 µg/mL." class="big_thumb" />